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Abstract
Purpose: To compare the perioperative outcomes of robot-assisted partial nephrectomy (RAPN) with open
partial nephrectomy (OPN) in solitary kidneys.
Methods: Records of 1542 consecutive RAPN performed in five high-volume centers (2007–2013) were reviewed
for patients with solitary kidneys. Results were compared with solitary OPN cases performed during the same
period. Cases were divided into simple (R.E.N.A.L. nephrometry score 4–8) and complex (R.E.N.A.L. 9–12) groups.
Demographics, surgical, pathologic, and follow-up data were compared between OPN and RAPN in each group.
Results: 40 RAPN and 85 OPN cases were identified. For both tumor complexity groups, patients in each
treatment modality were comparable. There were higher proportions of OPN cases in the complex group (61.2%
vs 25%; P = 0.001). For both complexity tumor groups, there was no statistical difference between the treatment
modalities in overall intraoperative/postoperative complications, transfusion rate, and positive surgical margin
(PSM) rates. Patients in the RAPN group had a shorter length of hospital stay. For the entire cohort, there was
no difference in estimated glomerular filtration rate preservation beyond 1 month (OPN 80.51%, RAPN
81.29%). Limitations include retrospective, nonrandomized nature of the series and small number of cases in
the RAPN groups.
Conclusions: In the solitary kidney, RAPN offers comparable perioperative and short-term functional outcomes
for localized tumors with low R.E.N.A.L. score. For more complex tumors, our early experience suggests com-
parability, but these results were obtained in selected cases and future studies will need to validate these results.
Introduction
Nephron-sparing surgery (NSS) is the current standardof care for the treatment of patients with small renal
masses.1 Solitary kidney is an imperative indication for per-
forming partial nephrectomy (PN). In the past two decades,
other modalities for definitive management of the small renal
mass have emerged, but PN remains the cornerstone of sur-
gical treatment in this setting.2
Although utility of robot-assisted partial nephrectomy
(RAPN) in this setting has been reported,3 there is a paucity
of data in the literature regarding comparison of this method
with the open technique. The previous publications have not
been comparative4 or only compared the outcomes of RAPN
with other minimally invasive techniques.5,6 Also, given the
selection biases associated with surgeon experience and
choice of modality of surgical approach, direct comparison of
results of different series without consideration of such fac-
tors as well as tumor complexity and patient characteristics is
not possible.
In this study, we aim to compare the perioperative outcomes
of RAPN with those of open partial nephrectomy (OPN) in
patients with solitary kidneys.
Method
After obtaining Institutional Review Board approval, we
retrospectively reviewed records of 1542 consecutive cases
of RAPN performed in five high-volume centers across the
United States from 2007 to mid-2013. We compared these
1Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio.
2Washington University School of Medicine, Department of Urology, St. Louis, Missouri.
3James Buchanan Brady Urological Institute, The Johns Hopkins Medical Institutions, Baltimore, Maryland.
4New York University School of Medicine, Department of Urology, New York, New York.
5Vattikuti Urology Institute, Henry Ford Health System, Detroit, Michigan.
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results with the results of OPN for clinically T1/T2 renal
neoplasms in solitary kidneys performed during the same
period. Our inclusion criteria encompassed NSS in the setting
of the solitary kidney. Cases where the contralateral kidney
contributed more than 10% toward total glomerular filtration
rate (GFR) were excluded from the study.
To make the groups comparable and to control for varia-
tions in tumor complexity across the two treatment arms, we
stratified cases according to the radius, exophytic/endophitic,
nearness to collecting system or sinus, anterior/posterior,
and location relative to polar lines (R.E.N.A.L.) nephrometry
score7 into simple (R.E.N.A.L. score 4–8) and complex
(R.E.N.A.L. score 9–12) groups.
The choice of surgical modality, OPN or RAPN, was at the
discretion of the primary surgeon and was decided on a case
by case basis. All procedures were performed by experienced
surgeons who were beyond their learning curves for the given
treatment modality. Demographics, surgical, pathologic, and
follow-up data were compared between OPN and RAPN
in each R.E.N.A.L. score complexity group. These included
age, sex, body mass index (BMI), Charlson Comorbidity
Index (CCI), proportion with CCI ‡ 5,8 American Society
of Anesthesiologists score, preoperative/pathologic tumor
size, ischemia time (cold and warm) and type, estimated
blood loss, operative time, intraoperative complications,
length of stay, pathologic data, postoperative complications,
and percentage (%) of GFR preservation on day 3 and beyond
3 months.
For the RAPN group, we also assessed the number of
solitary cases during each 500 RAPN cases performed by
all of the five surgeons (every 100 case per surgeon). GFR
was calculated by using the Modification of Diet in Renal
Disease formula. Percentage of GFR preservation was de-
fined as a ratio of postoperative GFR at 4 to 10 months
compared with the preoperative GFR. Chronic kidney dis-
ease (CKD) was defined as GFR <60mL/min/1.73m2.
Margin status was assessed by final pathologic evaluation.
Postoperative complications were graded according to the
Clavien classification.9
Continuous data with normal distribution variables are pre-
sented as mean– standard deviation. Mean values are com-
pared using the Student t test. For variables with nonnormal
distribution, data are presented as median (interquartile range
[IQR]), and the groups are compared using the Mann-Whitney
U test. Categorical variables are compared using the chi-square
test. Significance was set at P< 0.05. All analyses were per-
formed using SPSS v21 software (IBM SPSS Statistics, Ar-
monk, NY: IBM Corp).
Surgical technique
The surgical technique for RAPN was relatively similar
across the five participating institutions and has been de-
scribed previously.10,11 The transperitoneal route was used
in all the cases, and zero ischemia was used selectively. In-
tracorporeal renal parenchymal cooling was not used in any
of the RAPN cases.
OPN technique was relatively similar across the cohort and
has been described previously. The extraperitoneal flank
approach was used in the majority of cases, and parenchymal
cooling was used selectively. Intravenous mannitol was used
routinely for all OPN and RAPN cases.
Results
A total of 125 patients (40 RAPN and 85 OPN) were
identified for the comparison (Table 1). The mean age of the
cohort was 61.42– 11.1 years. Twenty (16%) patients had
a functionally solitary kidney ( <10% of function on renal
scan). From the patients with an anatomically solitary kidney,
82 (65.6%) patients had a history of radical nephrectomy.
Forty-one (32.8%) patients had a CCI of 5 or higher. Seventy-
two (57.6%) patients had a preoperative estimated GFR of
less that 60mL/min/1.73m2 (CKD). The median preopera-
tive tumor size was 3.5 cm (IQR 2.53). The median follow-up
time was 12 months (IQR 21.3).
During this time, five patients in the OPN and two patients
in the RAPN group died. There were two cancer-related death
in the OPN group and one cancer-related death in the RAPN
group. All the patients with cancer-related death had negative
surgical margins on final histologic evaluation. One of the
two patients in the OPN group had a 10 cm clear-cell renal-
cell carcinoma (RCC) (R.E.N.A.L. score 11, pT3a) and died 3
months postoperatively. The metastatic disease developed in
the other patient in the OPN group (R.E.N.A.L. score 10,
clear cell, pT1a), who died 4 years after the surgery. The
single cancer-related death in the RAPN group was in a pa-
tient with a high-grade papillary cancer (R.E.N.A.L. score 5,
pT1a) and history of contralateral radical nephrectomy (a
high-grade papillary cancer); malignant ascites developed in
the patient 1 year postoperatively. New CKD developed in 6
(16.2%) in the RAPN and 22 (26%) in the OPN group after
surgery (P = 0.5).
Figure 1 demonstrates the number of RAPN cases per-
formed according to volume experience for the operating
surgeons. With increasing experience, the number of RAPN
cases in a solitary kidney and the number of RAPN for a
complex tumor in a solitary kidney increased.
There were 63 patients allocated into the simple group
(R.E.N.A.L. score 4–8) and 62 into the complex group
(R.E.N.A.L. score 9–12). Higher proportions of OPN cases
were in the complex group (61.2% vs 25% for RAPN;
P= 0.001). The pathologic features and staging information
of the tumors for each treatment arm are listed in Table 2.
Simple tumor complexity group (R.E.N.A.L. score 4–8)
A total of 63 patients (30 RAPN and 33 OPN) had a
R.E.N.A.L. score of 4–8 (Table 3). There was no statistically
significant difference between the RAPN and OPN patients
in term of age, BMI, sex distribution, or proportions of pa-
tients with CCI of ‡5. There was no difference in median
Table 1. Patient Demographics
RAPN OPN P
Variables 40 85
Male sex, N (%) 32 (80) 54 (63.5) 0.06
Age, mean – SD (years) 61.3 – 10.7 61.5 – 11.4 0.92
BMI, mean – SD (kg/m2) 30– 5.4 31.7 – 6.6 0.17
CCI > 5, N (%) 6 (26.1) 35 (41.2) 0.19
Preop CKD, N (%) 21 (55.3) 51 (60) 0.62
RAPN = robot-assisted partial nephrectomy; OPN = open partia
nephrectomy; SD = standard deviation; BMI= body mass index;
CCI =Charlson Comorbidity Index; CKD= chronic kidney disease.
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R.E.N.A.L. score between the two groups (RAPN 6 vs OPN
7; P= 0.06). The intraoperative data were comparable be-
tween the two surgical methods; however, the median warm
ischemia time (WIT) in the RAPN group (15min) was shorter
than the median WIT in the OPN patients (23min) where this
was used. There was no difference between the groups in
terms of intraoperative complications (RAPN 3.3% vs OPN
0; P= 0.47). The single intraoperative complication belonged
to a patient in the RAPN group who required repair of renal
vein injury.
There was no difference between the groups in the rate of
postoperative complications. The high-grade complications
in the RAPN group consisted of two grade III complications,
one urine leak necessitating stent insertion, and one post-
operative bleeding from pseudoaneurysm necessitating se-
lective angioembolization. In the OPN group, high-grade
complications consisted of three grade III and four grade IV
complications. Grade III complications included two urine
leaks treated with stent insertion and one episode of urine
infection in a patient with a stent in situ necessitating stent
change. Grade IV complications consisted of two cases of
temporary dialysis and two intensive care unit (ICU) ad-
mission for nonurologic causes (pulseless cardiac arrest and
respiratory insufficiency).
The positive surgical margin (PSM) rates were comparable
between the two groups (RAPN 6.7% vs OPN 9%; P = 1.00).
The percentage of GFR preservation at the time of dis-
charge (RAPN 78.6– 23.2 vs OPN 65.3 – 33.2; P= 0.07) and
beyond 3 months postoperatively (RAPN 82.1– 22.7 vs OPN
88.4 – 32.3; P = 0.5) was similar between the two groups. The
hospital length of stay was shorter in the RAPN group (3 vs 5
days; P < 0.001).
Complex tumor complexity group (R.E.N.A.L. score 4–8)
A total of 62 patients (10 RAPN and 52 OPN) had a
R.E.N.A.L score of 9–12 (Table 4). With regard to age, BMI,
sex distribution, or proportions of patients with CCI of ‡5,
there was no statistically significant differences between
RAPN and OPN patients. There was no difference in me-
dian R.E.N.A.L. score between the two groups (RAPN 9.5 vs
OPN 10; P = 0.42). The intraoperative data were comparable
between the two surgical methods. There was a trend toward
higher rate of intraoperative complications (RAPN 10%
vs OPN 1.9%; P= 0.06) in RAPN patients. Intraoperative
complications included one case of small bowel serosal tear
in the RAPN group. In the OPN group, the complications
consisted of one pleural injury, necessitating repair and chest
tube insertion. In the RAPN group, all of the tumors were
resected with warm ischemia; the mean WIT was 22.7 – 5.8
minutes. In the OPN group, 25(48%) of tumors were removed
under warm ischemia, and the mean WIT was 23.9 – 8.1
minutes.
Postoperative complication rates were similar between
RAPN and OPN patients—40% and 38.5%, respectively
(P = 1.99). The high-grade complication in the RAPN group
consisted of a case of urinary leak (Clavien IIIb), which was
managed successfully with ureteral stent insertion. There
were three grade IV complications in the RAPN group. These
included one ICU admission for managing high blood pres-
sure and two cases of temporary dialysis. In the OPN arm,
there were six high-grade complications (three IIIs and three
IVs). The grade IIIs consisted of two postoperative bleedings
and one urinary leak. One of the two bleeding episodes ne-
cessitated selective angioembolization and the other one was
managed with a return to the operating roomwithout the need
for nephrectomy. The urinary leak was managed successfully
with urinary stent insertion. The grade IV complications in the
OPN group consisted of three cases of temporary renal dial-
ysis. Two had CKD stage II and one had CKD stage III pre-op
and all three upstaged one CKD stage after recovery.
The PSM rates were comparable between the two groups
(RAPN 10% vs OPN 7.7%; P = 0.5). The percentage of GFR
preservation at the time of discharge (RAPN 65.5 – 34.7 vs
OPN 55.4 – 26.4; P = 0.29) and at median 6-month follow-up
was (RAPN 80.3– 23.7 vs OPN 74 – 22; P = 0.4) similar
between the two groups. The hospital length of stay was
shorter in the RAPN group (4 vs 6 days; P = 0.001).
FIG. 1. Trends in utility of robot-assisted partial nephrec-
tomy (RPN) in patients with a solitary kidney depending
on tumor complexity. The data points, represent every 500
cases (100 per surgeon) performed during the surgeon’s RPN
experience.
Table 2. Pathologic Characteristics
RPN OPN
No. 40 85
Pathologic largest tumor
size, median (IQR) (cm)
2.8 (2.7) 3.7 (2)
Malignant, N (%)
T stage 33 (82.5%) 78 (92%)
T1a 21 (52.2%) 38 (44.7%)
T1b 7 (17.5%) 16 (18.8%)
T2 1 (2.5%) 2 (2.4%)
T3a 4 (10%) 22 (25.9%)
Histologic type, N (%)
Clear cell 17 (42.5%) 66 (77.6%)
Papillary 14 (35%) 9 (10.6%)
Chromophobe 2 (5%) 2 (2.4%)
Other 0 1 (1.2%)
Angiomyolipoma 2 (5%) 1 (1.2%)
Oncocytoma 3 (7.5%) 6 (7.1%)
Other 2 (5%) 0
RPN= robot-assisted partial nephrectomy; OPN = open partial
nephrectomy; IQR = interquartile range.
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Discussion
PN when possible is the absolute indication for manage-
ment of renal neoplasm in a solitary kidney. The initial ex-
perience with OPN was developed in this setting. With
growing experience, NSS has been performed for a variety
of tumors with relative or elective indications.1,2 Newer
minimally invasive techniques for NSS, however, have to be
tested and proven in these settings before their routine use
in the setting of solitary kidney. Previous publications have
compared the outcomes of OPN with laparoscopic partial
nephrectomy in the setting of solitary kidney.12 Before in-
troduction of tumor complexity classifications,7,13 however,
direct comparison between surgical techniques lacked this
objective factor. Typically, even in centers in which there is a
high level of minimally invasive experience, more complex
tumors are performed with OPN. As a result, if the tumor
anatomic complexity are not accounted for, more complica-
tions could be associated with the open approach.14
In this series, we divided the tumors according to com-
plexity, and although there are a higher percentage of com-
plex tumors performed with OPN (61.2% vs 25%), overall
the patients in each complexity group are comparable at
baseline. For the less complex tumors (R.E.N.A.L. score 4–
8), we have demonstrated that the RAPN and OPN are
comparable. There was no difference in terms of complica-
tions, PSM, and overall functional outcome between the two
surgical techniques. The rate of surgical margins in the
RAPN group (6.7%) is higher than our previously reported
rate of 2.2%15 for this technique. This rate is because of only
two cases of PSMs and mainly reflective of small cohort size,
but could also reflect an attempt by the surgeon to resect close
to the tumor to minimize the amount of parenchyma that is
being removed during the resection (enucleation).
While some authors have sanctioned surgical enucleation
with oncologic outcomes equivalent to standard PN,16 others
have advocated some although minimum healthy renal pa-
renchyma resection.17 Overall the incidence of PSM in the
solitary kidney PN series is higher than in patients with a
normal contralateral kidney.18 Also, there is controversy with
regard to considering surgical margins as a surrogate for
oncologic outcomes. Some studies have demonstrated that
PSM after PN increases the probability of local recurrence
without influencing cancer-specific survival,19 while others
have shown that PSM increases the risk of local recurrence as
well as metastasis.15
The median WIT for simple tumors was 15 (IQR 9) min-
utes, which is within the safe range of <25 minutes described
by Thompson and associates.20 Although a growing body of
evidence suggests that the amount of renal parenchyma re-
moved rather than WIT is the determinant of final degree
renal function preservation,21,22 long WIT, especially in the
Table 3. Perioperative Outcomes of Robot-Assisted Partial Nephrectomy
and Open Partial Nephrectomy for Simple Renal Masses
Simple tumors (R.E.N.A.L. score 4–8)
RPN OPN P
No. 30 33
Pathologic largest tumor size, median (IQR) (cm) 2.5 (2.35) 3.5 (1.6) 0.29
R.E.N.A.L. score, median (IQR) 6 (2) 7 (3) 0.06
Tumors per kidney, median (IQR) 1 (0) 1 (1) 0.09
Operative time, mean – SD (min) 174.9 – 61.7 185.42– 56.4 0.49
EBL, median (IQR) (ml) 200 (300) 300 (300) 0.07
Ischemic time (min)
Warm
N, % 21, 70 18, 54.7
Median (IQR) 15 (9) 23 (19) 0.03
Cold
N, % 1, 3.3 7, 21.2
Mean – SD 8 42.33 – 12.8
No ischemia 8, 26.7 8, 24.2
Intraoperative complications, N (%) 1 (3.3%) 0 0.47
Transfusion, N (%) 6 (20%) 5 (15.2%) 0.61
Postoperative complications, N (%) 9 (30%) 16 (48.5%) 0.13
Clavien score
I
II 3 (10%) 6 (18.2%) 0.33
IIIa 4 (13%) 3 (9.1%)
IIIb 1 (3.3%) 1 (3%)
IVa 1 (3.3%) 2 (6.1%)
0 (0%) 4 (12.1%)
Hospital stay, median (IQR) (days) 3 (5) 5.5 (3) 0.001
Positive margin, N (%) 2 (6.7%) 3 (9%) 1.00
Follow-up time, Median (IQR) (months) 7.8 (18.7) 14 (14.5) 0.29
R.E.N.A.L. = radius, exophytic/endophitic, nearness to collecting system or sinus, anterior/posterior, and location relative to polar lines;
RAPN = robot-assisted partial nephrectomy; OPN= open partial nephrectomy; IQR = interquartile range; SD = standard deviation;
EBL = estimated blood loss.
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setting of preexisting renal impairment and solitary kidney,
is an important modifiable factor.23–26 The rates of intra-
operative (3.3%) and postoperative complications (30%)
are slightly higher than in some of the published RAPN se-
ries,27 but they are comparable with results from other OPN
series for solitary kidneys.12,28,29 From a functional point of
view, with the mean follow-up time of 12 months, the degree
of GFR preservation was >80% (82.1 – 22.7) for the RAPN
patients with low tumor complexity. This is similar to pre-
vious published results for OPN series.12 The main differ-
ence between the open and robotic group was 2 days shorter
hospital stay in favor of the robotic cohort.
For more complex tumors, our results were similar be-
tween the two treatment arms; however, a significantly larger
number of cases were performed with the OPN technique.
The rate of intraoperative complications in the RAPN group
was 10%, and this was not statistically significantly different
from the 1.9% in the OPN group (P = 0.06). Both of these
values were because of a single intraoperative event in each
treatment arm, and it is fair to assume that the intraoperative
complications were similar between the two groups. Larger
cumulative experience with the OPN and also the ability to
perform the procedure under a cool ischemia condition al-
lows the surgeon to perform complex tumor resection and
reconstruction with good functional and oncologic outcomes
and acceptable morbidity.12,24,30 Although this series has
demonstrated that RAPN in a solitary kidney with a tumor
with high nephrometry score is feasible, these results were
obtained in high-volume robotic centers and by very expe-
rienced robotic surgeons.
Overall, the cumulative robotic experience in this setting is
very limited and OPN remains the gold standard technique
for treating complex tumors in patients with a solitary kidney.
Future developments in RAPN techniques, including in-
tracorporeal cooling,31 will allow urologists to further their
experience in the setting of PN and reproduce every aspect of
the open technique with a minimally invasive approach.
One criticism of this study is that the selection of cases for
the modality of PN was not randomized, and this is likely a
source of bias. With early RAPN experience, only simple
tumors were selected for this approach, but as shown in
Figure 1, with increasing experience, more complex tumors
in a solitary kidney were managed using this modality. De-
spite this, a larger volume of complex tumors in this setting
were managed with the OPN approach. The stratification of
the tumors according to complexity allowed us to compare
the outcomes between the two approaches, but overall vol-
ume experience for RAPN in this setting remains limited.
Table 4. Perioperative Outcomes of Robot-Assisted Partial Nephrectomy
and Open Partial Nephrectomy for Complex Renal Masses
Complex tumors (R.E.N.A.L. score 9–12)
RPN OPN P
No. 10 52
Pathologic largest tumor size, median (IQR) (cm) 4.15 (2.9) 4.3 (2.1) 0.3
R.E.N.A.L. score, median (IQR) 9.5 (1) 10 (1) 0.42
Tumors per kidney median (IQR) 1 (1) 1 (0) 0.63
Operative time, mean – SD (min) 250.8 – 66 244.1– 5 9.3 0.75
EBL, median (IQR) (mL) 225 (288) 300 (263) 0.14
Ischemic time (min)
Warm
N, % 10, 100 25, 48
Mean – SD 22.7– 5.8 23.9– 8.1 0.66
Cold
N, % 27, 52 —
Mean – SD —– 46.9 – 18.4 —
Intraoperative complications, N (%) 1 (10%) 1 (1.9%) 0.06
small bowel pleural injury
serosal tear requiring chest tube
Transfusion, N (%) 0 8 (15.4%) 0.33
Postoperative complications, N (%) 4 (40%) 20 (38.5%) 1.00
Clavien score
I
II 0 10 (19.2%) 0.09
IIIa 0 4 (7.7%)
IIIb 0 0
IVa 1 (10%) 3 (5.8%)
3 (30%) 3 (5.8%)
Hospital stay, median (IQR) (days) 4 (1.5) 6 (2) 0.001
Positive margin, N (%) 1 (10%) 4 (7.7%) 0.5
Follow-up time, median (IQR), (months) 4 (18) 19.6 (29.7) 0.65
R.E.N.A.L.= radius, exophytic/endophitic, nearness to collecting system or sinus, anterior/posterior, and location relative to polar
lines; RPN = robot-assisted partial nephrectomy; OPN= open partial nephrectomy; IQR= interquartile range; SD = standard deviation;
EBL = estimated blood loss.
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For tumor stratification based on the R.E.N.A.L. score,
other authors have previously used a simple (R.E.N.A.L. 4–
6), intermediate (R.E.N.A.L. 7–9), and complex (R.E.N.A.L.
10–12) division.32 Given the small number of cases in the
RAPN group, we devised a two-group classification to allow
for adequate number of cases for analysis. This, although
unlikely to affect the results, but could make future com-
parison to the results of this study challenging.
Another criticism that could be raised is lack of matching
between the two groups in the study design. By finding a
matching case for every RAPN patient in the OPN groups,
many of the complex cases in the OPN group would have
been eliminated from the series. This could have falsely given
the impression of comparability, because percentages of
complex tumors between the two treatment modalities would
have appeared similar and also would have further reduced
the size of the already small, solitary kidney PN cohort.
Given the small number of cases and small number of events
of interests (complications, PSM), we did not perform any
multivariable analysis in this study. Trifecta and margin,
ischemia, and complication are some of the composite
outcomes that have previously been proposed for assessing
perioperative outcomes associated with PN27,33,34; how-
ever, given the liberal use of cold ischemia in OPN, direct
comparison of clamp time between the two groups was not
possible.
Retrospective, multi-institutional design of this cohort
could have affected certain aspects of our results. For ex-
ample, the reporting of intraoperative complications was not
standardized, and it is likely that minor complications, such
as a small pleural/peritoneal tear in the OPN group or minor
issues such as difficulty with establishing pneumoperitoneum
in the RAPN group, were not readily reported.
This study represents the largest series of RAPN in the
setting of a solitary kidney. It also represents the only com-
parative study comparing the outcomes with OPN. The lim-
itations include the retrospective, nonrandomized nature of
the series and the small number of cases in the RAPN groups,
particularly the small number of patients with complex tu-
mors. The follow-up is relatively short, and longer follow-up
data are needed.
Conclusion
In the setting of NSS in a solitary kidney, presuming
careful patient selection and adequate surgical experience,
RAPN may offer comparable perioperative and short-term
functional outcomes for localized renal masses with low
R.E.N.A.L. score when compared with OPN. For more
complex tumors, our early experience suggests comparabil-
ity, but these results were obtained in selected cases and by
high-volume surgeons. Future studies will need to validate
these results.
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Abbreviations Used
BMI¼ body mass index
CCI¼Charlson Comorbidity Index
CKD¼ chronic kidney disease
GFR¼ glomerular filtration rate
ICU¼ intensive care unit
IQR¼ interquartile range
NSS¼ nephron sparing surgery
OPN¼ open partial nephrectomy
PN¼ partial nephrectomy
PSM¼ positive surgical margin
RAPN¼ robot-assisted partial nephrectomy
R.E.N.A.L.¼ radius, exophytic/endophitic, nearness
to collecting system or sinus, anterior/
posterior, and location relative to polar
lines
RAPN¼ robot-assisted partial nephrectomy
WIT¼warm ischemia time
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